RESEARCH ARTICLE > OPEN ACCESS
The JAK1/2 inhibitor ruxolitinib reverses interleukin-6-mediated suppression of drug detoxifying proteins in cultured human hepatocytes
at the Technion-Israel Institute of Technology
at the Technion-Israel Institute of Technology
Figures()
Tables()